HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by TD Asset Management Inc.

TD Asset Management Inc. lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 1.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 742,599 shares of the company’s stock after selling 14,236 shares during the quarter. TD Asset Management Inc. owned 0.29% of HCA Healthcare worth $222,891,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of HCA. FMR LLC grew its stake in HCA Healthcare by 322.3% during the 3rd quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares in the last quarter. Royal London Asset Management Ltd. increased its stake in shares of HCA Healthcare by 62.0% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock worth $450,461,000 after buying an additional 574,239 shares during the period. Principal Financial Group Inc. lifted its stake in HCA Healthcare by 120.1% in the fourth quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock worth $262,264,000 after acquiring an additional 476,756 shares during the last quarter. Meritage Group LP purchased a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $150,548,000. Finally, Raymond James Financial Inc. acquired a new position in shares of HCA Healthcare during the fourth quarter worth $74,121,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.60% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. KeyCorp decreased their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Morgan Stanley decreased their price objective on shares of HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating for the company in a research note on Tuesday, December 17th. Finally, Truist Financial reduced their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Stock Performance

Shares of HCA opened at $336.12 on Wednesday. The stock has a market capitalization of $82.75 billion, a P/E ratio of 15.30, a P/E/G ratio of 1.10 and a beta of 1.68. The company’s fifty day moving average is $322.63 and its two-hundred day moving average is $341.89. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the firm posted $5.90 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.